• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Model Number VBJR062502A
Device Problem Activation Failure (3270)
Patient Problem No Code Available (3191)
Event Date 03/05/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).A review of the manufacturing records indicated the lot met pre-release specifications.The entire device and introducer sheath were returned.The introducer sheath was not evaluated as it is not a gore product.Engineering evaluation conclusion(s) are: partial deployment-partial device expansion and partial deployment-deployment line stuck.Based on the evaluation performed, no manufacturing anomalies were identified to which the event could be definitively attributed.
 
Event Description
It was reported to gore: on (b)(6) 2020 a patient underwent the treatment of the right superficial femoral artery occlusion using left leg access.A 6 mm x 25 cm gore® viabahn® endoprosthesis (viabahn) was intended to be placed in the femoral artery using a 6fr sheath.Over the v18 wire the physician began to pull the deployment line and 4 cm of the viabahn started to deploy before the physician could no longer pull the deployment line.The physician tried a little more pressure while pulling but the device would not deploy.The physician had to pull the device back to the sheath, however the viabahn would not collapse back into the sheath.Everything except the wire was pulled back through the access site.A new sheath was inserted along with a new 6 mm x 25 cm gore viabahn device and was deployed with no issue.As reported, there were no pre-existing devices at intended treatment site.Manual pressure was held at the access site during the procedure, however the patient was brought back to repair a tear and remove plaque at the access site the next day.The patient tolerated the procedures and is doing well.
 
Manufacturer Narrative
Instructions for use for gore® viabahn® endoprosthesis with heparin bioactive surface warnings section state: do not withdraw the gore® viabahn® endoprosthesis with heparin bioactive surface back into the introducer sheath once the endoprosthesis is fully introduced.Withdrawing the gore® viabahn® endoprosthesis with heparin bioactive surface back into the sheath can cause damage to the endoprosthesis, premature deployment, deployment failure, and / or catheter separation.If removal prior to deployment is necessary, withdraw the gore® viabahn® endoprosthesis with heparin bioactive surface to a position close to but not into the introducer sheath.Both the gore® viabahn® endoprosthesis with heparin bioactive surface and introducer sheath can then be removed in tandem.After removal, do not reuse the gore® viabahn® endoprosthesis with heparin bioactive surface or introducer sheath.
 
Event Description
The following was reported to gore: on (b)(6) 2020, a patient underwent treatment of the right superficial femoral artery occlusion.From contralateral access, a 6 mm x 25 cm gore® viabahn® endoprosthesis (viabahn device) was intended to be advanced through a 6fr sheath over a v18 wire.As reported, there were no pre-existing devices and the intended treatment area was pre-ballooned.The viabahn device was placed and the physician began to pull the deployment line.About 4 cm of the viabahn device expanded when the deployment line became stuck.The physician tried a little more pressure while pulling the deployment line, but the device did not continue to expand.The physician attempted to pull the partially expanded device back into the sheath, but viabahn device did not collapse back into the sheath.The viabahn device and sheath were pulled out, causing a tear at the access site.A new sheath was inserted, and a new 6 mm x 25 cm viabahn device was advanced and deployed with no issues.It was reported that manual pressure was applied to the access site during the procedure.The next day, the access site tear was repaired and plaque was also removed.The patient tolerated the procedure and is doing well.The physician stated he suspected the event was due to deployment line getting wrapped around the catheter during deployment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9917200
MDR Text Key193641143
Report Number2017233-2020-00226
Device Sequence Number1
Product Code PFV
UDI-Device Identifier00733132623976
UDI-Public00733132623976
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 07/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/29/2022
Device Model NumberVBJR062502A
Device Catalogue NumberVBJR062502A
Device Lot Number21651718
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/11/2020
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age72 YR
-
-